PFE

Pfizer (PFE)

Pfizer Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:PFE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	20:21	IH Market News	Adobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and More	NYSE:PFE	Pfizer Inc
2024/06/14	16:00	Business Wire	ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma	NYSE:PFE	Pfizer Inc
2024/06/13	05:30	Business Wire	Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy	NYSE:PFE	Pfizer Inc
2024/06/12	03:43	Edgar (US Regulatory)	Form 11-K - Annual report of employee stock purchase, savings and similar plans	NYSE:PFE	Pfizer Inc
2024/06/12	03:39	Edgar (US Regulatory)	Form 11-K - Annual report of employee stock purchase, savings and similar plans	NYSE:PFE	Pfizer Inc
2024/06/10	20:29	IH Market News	Apple Showcases AI at WWDC 2024, Nvidia Stock Split Starts Today, and More News	NYSE:PFE	Pfizer Inc
2024/06/06	05:05	GlobeNewswire Inc.	Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608	NYSE:PFE	Pfizer Inc
2024/06/05	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/06/05	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/06/04	07:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/06/03	23:00	Business Wire	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference	NYSE:PFE	Pfizer Inc
2024/06/01	21:00	Business Wire	Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)	NYSE:PFE	Pfizer Inc
2024/06/01	21:00	Business Wire	Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma	NYSE:PFE	Pfizer Inc
2024/06/01	01:15	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:PFE	Pfizer Inc
2024/05/31	21:00	Business Wire	Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression	NYSE:PFE	Pfizer Inc
2024/05/23	20:40	IH Market News	OpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More News	NYSE:PFE	Pfizer Inc
2024/05/23	01:39	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:PFE	Pfizer Inc
2024/05/17	00:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/05/17	00:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/05/16	20:27	IH Market News	Chubb Stock Soars 9% with Berkshire Acquisition, AST SpaceMobile jumps 37% on AT&T deal, and More News	NYSE:PFE	Pfizer Inc
2024/05/16	19:00	GlobeNewswire Inc.	Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)	NYSE:PFE	Pfizer Inc
2024/05/13	21:00	PR Newswire (US)	Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting	NYSE:PFE	Pfizer Inc
2024/05/13	20:16	IH Market News	Arm Sets 2025 Target for AI Chip Development, Amazon and Microsoft Commit Billions to French Investments, and More	NYSE:PFE	Pfizer Inc
2024/05/09	22:01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:PFE	Pfizer Inc
2024/05/09	20:53	IH Market News	Bain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More News	NYSE:PFE	Pfizer Inc
2024/05/09	04:56	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:PFE	Pfizer Inc
2024/05/06	19:45	Business Wire	Pfizer Announces New Chief Strategy and Innovation Officer	NYSE:PFE	Pfizer Inc
2024/05/01	22:12	IH Market News	CVS Health, Starbucks, Shares Weaker; Pinterest Soars	NYSE:PFE	Pfizer Inc
2024/05/01	19:45	Business Wire	Pfizer Reports First-Quarter 2024 Results	NYSE:PFE	Pfizer Inc
2024/04/30	07:40	Business Wire	FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer	NYSE:PFE	Pfizer Inc